METabolic EXplorer S.A.

ENXTPA:METEX Stock Report

Market Cap: €6.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

METabolic EXplorer Past Earnings Performance

Past criteria checks 0/6

METabolic EXplorer's earnings have been declining at an average annual rate of -239.2%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 36.4% per year.

Key information

-239.21%

Earnings growth rate

-166.54%

EPS growth rate

Chemicals Industry Growth10.42%
Revenue growth rate-36.39%
Return on equity-51.87%
Net Margin-29.34%
Last Earnings Update30 Jun 2023

Recent past performance updates

Analysis Article Oct 06

Statutory Earnings May Not Be The Best Way To Understand METabolic EXplorer's (EPA:METEX) True Position

We didn't see METabolic EXplorer S.A.'s ( EPA:METEX ) stock surge when it reported robust earnings recently. We decided...

Recent updates

Analysis Article Feb 10

METabolic EXplorer S.A. (EPA:METEX) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Those holding METabolic EXplorer S.A. ( EPA:METEX ) shares would be relieved that the share price has rebounded 28% in...
Analysis Article Dec 18

Why Investors Shouldn't Be Surprised By METabolic EXplorer S.A.'s (EPA:METEX) 27% Share Price Plunge

To the annoyance of some shareholders, METabolic EXplorer S.A. ( EPA:METEX ) shares are down a considerable 27% in the...
Analysis Article Oct 01

Health Check: How Prudently Does METabolic EXplorer (EPA:METEX) Use Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analysis Article Jul 30

News Flash: One METabolic EXplorer S.A. (EPA:METEX) Analyst Has Been Trimming Their Revenue Forecasts

The latest analyst coverage could presage a bad day for METabolic EXplorer S.A. ( EPA:METEX ), with the covering...
Analysis Article Jul 10

Downgrade: The Latest Revenue And EPS Forecasts For METabolic EXplorer S.A. (EPA:METEX)

Market forces rained on the parade of METabolic EXplorer S.A. ( EPA:METEX ) shareholders today, when the covering...
Analysis Article Jun 14

Does METabolic EXplorer (EPA:METEX) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article May 10

Is METabolic EXplorer S.A. (EPA:METEX) Potentially Undervalued?

METabolic EXplorer S.A. ( EPA:METEX ), might not be a large cap stock, but it saw a double-digit share price rise of...
Analysis Article Jan 25

What Is METabolic EXplorer S.A.'s (EPA:METEX) Share Price Doing?

METabolic EXplorer S.A. ( EPA:METEX ), might not be a large cap stock, but it saw a decent share price growth in the...
Analysis Article Oct 06

Statutory Earnings May Not Be The Best Way To Understand METabolic EXplorer's (EPA:METEX) True Position

We didn't see METabolic EXplorer S.A.'s ( EPA:METEX ) stock surge when it reported robust earnings recently. We decided...
Analysis Article May 12

METabolic EXplorer (EPA:METEX) Has Debt But No Earnings; Should You Worry?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Mar 18

The METabolic EXplorer (EPA:METEX) Share Price Has Soared 428%, Delighting Many Shareholders

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
Analysis Article Dec 03

Investors Who Bought METabolic EXplorer (EPA:METEX) Shares A Year Ago Are Now Up 74%

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...

Revenue & Expenses Breakdown

How METabolic EXplorer makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:METEX Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23168-49309
31 Mar 23198-50329
31 Dec 22228-513310
30 Sep 22246-333310
30 Jun 22264-153310
31 Mar 2221834299
31 Dec 2117283248
30 Sep 2110579177
30 Jun 21387596
31 Mar 21203376
31 Dec 202-946
30 Sep 202-956
30 Jun 202-856
31 Mar 202-856
31 Dec 192-855
30 Sep 193-955
30 Jun 193-955
31 Mar 194-855
31 Dec 186-655
30 Sep 186-956
30 Jun 187-1156
31 Mar 187-1146
31 Dec 177-1146
30 Sep 176-146
30 Jun 176846
31 Mar 175747
31 Dec 164747
30 Sep 164047
30 Jun 164-747
31 Mar 163-747
31 Dec 153-746
30 Sep 154-746
30 Jun 154-645
31 Mar 155-545
31 Dec 146-445
30 Sep 144-344
30 Jun 143-243
31 Mar 142-342
31 Dec 131-441

Quality Earnings: METEX is currently unprofitable.

Growing Profit Margin: METEX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if METEX's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare METEX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: METEX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-31.3%).


Return on Equity

High ROE: METEX has a negative Return on Equity (-51.87%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/09 18:32
End of Day Share Price 2024/10/09 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

METabolic EXplorer S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arsene GuekamCIC Market Solutions (ESN)
Nicolas RoyotPortzamparc BNP Paribas
Christophe Dombu YoutaPortzamparc BNP Paribas